Clinical trial
HCC Risk and Monitoring in Patients With Type 2 Diabetes
NCT07675187
Study timeline
Study start (estimated)2026-07-01Date precision: day
Registry last updated2026-07-07
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Type 2 Diabetes (T2DM)unresolved
Hepatocellular Carcinoma (HCC)unresolved
Interventions
GAAD scoreDIAGNOSTIC_TEST
Sponsors & collaborators
National Taiwan University Hospitallead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT07675187 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.